Medical Oncology
肿瘤内科 · The Second Hospital of Lanzhou University, Lanzhou
The Department of Medical Oncology provides comprehensive care for patients with various malignant tumors. Led by Dr. Song Feixue, the team offers chemotherapy, biological immunotherapy, anti-angiogenic therapy, hyperthermia, traditional Chinese medicine, and palliative care. The department operates 38 beds, including eight laminar flow beds, and aims to align its diagnostic and treatment techniques with international standards. With a staff of 19 medical professionals, the unit focuses on integrated medical, educational, and research activities. It serves approximately 1,500 outpatients and admits around 900 inpatients annually, emphasizing patient-centered care in a supportive environment.
Conditions and treatments
- Chemotherapy for malignant tumors
- Biological immunotherapy
- Anti-angiogenic therapy
- Hyperthermia treatment
- Traditional Chinese medicine therapy
- Palliative care
Key facts
- The department has 19 staff members, including 9 doctors and 10 nurses.
- The unit operates 38 beds, including 8 laminar flow beds.
- Annual volume includes approximately 1,500 outpatient visits and 900 admitted patients.
Rewritten in English from the department's own description on a public doctor-listing platform. Claims such as "leading" are the hospital's own.
| Specialty | Medical Oncology |
|---|---|
| Doctors listed | 6 |
| Chief physicians | 2 |
Senior doctors
Chief and associate chief physicians listed for this department on public doctor-listing platforms (2025–2026).
Chief physicians
- Feixue Song宋飞雪 · Associate Professor
- Guixiang Li李桂香
Associate chief physicians
- Na Wang王娜 · Lecturer
- Yating Liu刘雅婷
- Bin Xiong熊彬 · Lecturer
- Lili Yu鱼丽莉
We are an independent coordination service, not part of this hospital. Names and titles change; the hospital's website is the final word. How we build this directory.
Need a specialist's opinion?
Send your records and question. We find a specialist in the right field who reviews your case and tells you what they recommend.
Contact us